Molnupiravir
Form: Tablets
Strength: 800 mg
Reference Brands:
Category: Anti Covid Medicines
The US Food and Drug Administration (FDA) has authorized emergency use of molnupiravir for the treatment of mild-to-moderate COVID-19 in people 18 years of age and older: testing positive for COVID-19; who are at high risk for progression to severe COVID-19, including hospitalization or death; and for whom other COVID-19 treatment options are not available or applicable.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Baricitinib
Strength: 2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View Details Get Enquiry
Nirmatrelvir + Ritonavir
Strength: Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details Get Enquiry
Tocilizumab
Strength: IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details Get Enquiry
Molnupiravir
Strength: 200 mg
Form: Oral capsule
Reference Brands: Lagevrio®(Us & EU)
View Details Get Enquiry